Add BrightSurf on Google Email

A video-based decision support tool may aid decision-making for Black individuals considering ICD implantation

A randomized clinical trial found that a video-based decision support tool increased patient knowledge, but not assent, to ICD implantation among Black patients. The study also highlighted the complexity of aversion to cardiac procedures in Black communities, emphasizing the need for further research on social determinants of health.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeRandomized controlled/clinical trial·DateApr 3, 2023

Smart watches could predict higher risk of heart failure

A new study published in The European Heart Journal – Digital Health found that smart watch data can predict a higher risk of developing heart failure and irregular heart rhythms. Researchers used machine learning to analyze ECG recordings from wearable devices and identified extra beats as indicators of increased cardiovascular risk.

SourceUniversity College London·JournalEuropean Heart Journal - Digital Health·TypeData/statistical analysis·DateApr 3, 2023

New mechanisms and therapeutic possibilities for heart failure uncovered by scientists at the Lewis Katz School of Medicine at Temple University and Johns Hopkins University

Researchers at Temple University and Johns Hopkins University found that brain-derived neurotrophic factor (BDNF) loss underlies post-myocardial infarction heart failure. BDNF levels can be replenished therapeutically, abolishing damage to heart tissue and enabling recovery.

SourceTemple University Health System·JournalCirculation Research·DateMar 30, 2023

The shape of your heart matters

Researchers from the Smidt Heart Institute found that individuals with spherical hearts are 31% more likely to develop atrial fibrillation and 24% more likely to develop cardiomyopathy. The study identified four genes associated with cardiomyopathy and a greater risk of developing atrial fibrillation.

Study shows ‘obesity paradox’ does not exist: waist-to-height ratio is a better indicator of outcomes in patients with heart failure than BMI

A new study published in the European Heart Journal shows that using waist-to-height ratio instead of BMI provides a clearer picture of patient outcomes in heart failure. The researchers found that greater adiposity is associated with worse outcomes, including high rates of hospitalization and reduced health-related quality of life.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeObservational study·DateMar 21, 2023

Mending broken hearts using bio-printed ‘patches’

Researchers at University of Technology Sydney have successfully created personalized 'bio-inks' from patients' own stem cells, which are then used to 3D-print cardiac tissues to repair areas of dead tissue. This technology shows promise in treating heart failure and may reduce the need for expensive and traumatic heart transplants.

SourceUniversity of Technology Sydney·JournalBioprinting·TypeExperimental study·DateMar 12, 2023

Mass General Brigham study finds virtual care team strategy improved treatment for heart failure patients

A virtual care team consisting of physicians and pharmacists improved the adoption of life-saving therapies in patients with heart failure, leading to increased use of evidence-based treatments and better patient outcomes. The strategy was safe and effective, with comparable length of stay and safety events between the groups.

SourceMass General Brigham·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateMar 6, 2023

Increased hospitalizations for heart attacks, heart failure seen in older adults living near fracking sites

A University of Chicago study found that older adults living near fracking sites in Pennsylvania had higher rates of cardiovascular disease hospitalizations compared to those in nearby New York state. The study linked exposure to air and water pollution from fracking activity to increased health outcomes.

SourceUniversity of Chicago Medical Center·JournalThe Lancet Planetary Health·DateMar 6, 2023

Transcatheter mitral valve repair in heart failure patients significantly reduces hospitalizations and improves survival

A new study shows that transcatheter mitral valve repair significantly reduces hospitalizations by almost 50 percent and death by nearly 30 percent in heart failure patients with severe mitral regurgitation. The procedure, using Abbott's MitraClip system, improves symptoms, reduces hospitalizations, and leads to longer survival.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMar 5, 2023

Home-based cardiac rehabilitation may help people live longer

A new study published in the Journal of the American Heart Association found that participating in home-based cardiac rehabilitation was associated with a 36% lower likelihood of death from heart-related complications among US military veterans within four years. The study analyzed data from 1,120 veterans who enrolled in a 12-week hom...

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateMar 1, 2023

Cleveland researchers reveal how oxygen is delivered to tissues, open door to new class of drugs

Researchers at University Hospitals Cleveland Medical Center discovered that S-nitrosohemoglobin senses areas with insufficient oxygen and restores blood flow for oxygenation. This breakthrough opens up a new line of drug development to correct poor tissue oxygenation, including peripheral artery disease and sickle cell disease.

SourceUniversity Hospitals Cleveland Medical Center·JournalProceedings of the National Academy of Sciences·DateMar 1, 2023

The Texas Heart Institute delivers a new first in heart failure treatment using cell therapy

A new cell therapy has demonstrated significant benefits in improving the heart's pumping ability and reducing the risk of cardiovascular death, heart attack, or stroke in patients with chronic heart failure. The therapy, using mesenchymal precursor cells (MPCs), also showed a strong signal in reducing inflammation and improving microv...

SourceTexas Heart Institute·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateFeb 27, 2023

Heart failure places a great strain on healthcare

A multinational study of over 600,000 heart failure patients found that the disease is relatively fatal, with an average annual death rate of 13%, and results in high healthcare costs. The study also identified new treatment opportunities for heart failure with preserved left ventricular function.

SourceKarolinska Institutet·JournalHeart·TypeObservational study·DateFeb 13, 2023

Donor hearts can be reprogrammed with medication for longer storage, improved transplant outcomes

A new study found that a medication previously used to treat seizures can reprogram donor hearts to boost the production of beneficial enzymes, increasing storage time and improving post-transplant function. This technology could lead to a paradigm shift in extending heart storage and reducing primary graft dysfunction.

SourceMichigan Medicine - University of Michigan·JournalScience Translational Medicine·TypeExperimental study·DateFeb 8, 2023

Heart failure risk higher in rural areas

A large observational study found that heart failure risk is 19% higher for adults living in rural areas of the US compared to urban areas, with a significant disparity in Black men. The study highlights race- and sex-based inequities in heart failure risk, emphasizing the need for targeted interventions to prevent heart failure.

SourceVanderbilt University Medical Center·JournalJAMA Cardiology·DateJan 25, 2023

Association of rurality with risk of heart failure

A study published in JAMA Cardiology found that rurality is associated with a higher risk of heart failure among predominantly low-income individuals in the southeastern United States. The inequity highlights the need for targeted primary prevention efforts for rural populations.

SourceJAMA Network·JournalJAMA Cardiology·DateJan 25, 2023

Anti-ageing gene shown to rewind heart age by 10 years

Researchers have discovered an anti-ageing gene that can rewind the heart's biological age by 10 years, offering a potential target for patients with heart failure. The study found that administering the healthy mutant gene to elderly patients with severe heart problems improved their cardiac function and rejuvenated their immune system.

SourceUniversity of Bristol·JournalCardiovascular Research·TypeExperimental study·DateJan 23, 2023

Comparison of diuretics shows no difference in heart failure survival

A large clinical trial supported by the National Institutes of Health found that two widely used diuretics, furosemide and torsemide, did not differ in improving patient survival when compared. The study suggests a need for better treatments for heart failure patients and highlights the importance of optimizing diuretic doses to improv...

SourceNIH/National Heart, Lung and Blood Institute·JournalJournal of the American Medical Association·DateJan 17, 2023

Nuclear medicine bone scan study identifies prevalence and outcomes of cardiac amyloidosis

A new study found that approximately three percent of all bone scan patients have markers of cardiac amyloidosis, which can lead to heart failure and increased mortality. The research highlights the importance of early diagnosis and treatment, as well as potential automated detection methods using machine-learning algorithms.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJan 3, 2023

Lonely heart-failure patients face worse outcomes than sociable peers

A new study found that older heart failure patients who feel they have lost their social role amongst friends and family are more likely to suffer poor clinical outcomes. The study highlights the need for a management program that includes a social approach to care, as social frailty is linked to worse outcomes.

SourceFrontiers·JournalFrontiers in Cardiovascular Medicine·TypeObservational study·DateDec 20, 2022

Mouse study suggests new therapeutic strategy to reduce cardiovascular disease in cancer survivors

Researchers at Memorial Sloan Kettering Cancer Center discovered that common cancer treatments cause long-term damage to heart tissue by activating a key inflammatory signaling pathway. Inhibiting this pathway may reduce the risk of cancer survivors developing heart disease later in life.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·TypeExperimental study·DateDec 19, 2022

Albert Einstein College of Medicine and Montefiore Health System receive $5.2 Million NIH grant to study heart failure in Hispanic populations

Researchers will investigate the relationship between heart function and aorta stiffness to identify risk factors for heart failure in Hispanics/Latinos, who are disproportionately affected by this condition. The study aims to develop new methods for predicting and preventing heart failure in underrepresented populations.

Novel wearable belt with sensors accurately monitors heart failure 24/7

Researchers from Florida Atlantic University have developed a prototype of a novel wearable device that can continuously monitor physiological parameters associated with heart failure in real-time. The device uses sensors embedded in a lightweight belt to track thoracic impedance, electrocardiogram, heart rate, and motion activity, pro...

SourceFlorida Atlantic University·JournalScientific Reports·TypeExperimental study·DateDec 12, 2022

A new therapeutic target for the prevention of heart failure due to aortic stenosis

A new gene therapy approach has been developed to boost the expression of the beta-3 adrenergic receptor in heart cells, improving mitochondrial function and preventing or reversing heart failure in a mouse model of aortic stenosis. This could potentially provide new therapeutic options for patients with this condition.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalBasic Research in Cardiology·TypeExperimental study·DateNov 30, 2022

Blinding eye disease strongly associated with serious forms of cardiovascular disease

A new study from Mount Sinai Hospital finds a strong association between age-related macular degeneration and severe forms of heart disease, including heart failure, heart attacks, and stroke. The study highlights the importance of increased screening for eye disorders to diagnose undetected heart disease.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalBMJ Open Ophthalmology·TypeImaging analysis·DateNov 17, 2022

Severe obesity in youth a risk factor for early atrial fibrillation

A University of Gothenburg study found that severe obesity at age 18 is associated with a three- to fourfold increased risk of developing atrial fibrillation in younger middle age. The study analyzed data from over 1.7 million men in Sweden and found that higher BMI was linked to mortality risk, heart failure, and ischemic stroke.

SourceUniversity of Gothenburg·JournalJournal of the American Heart Association·TypeData/statistical analysis·DateNov 9, 2022

Study shows heart failure treatment with dapagliflozin consistently benefited both men and women

A recent study by Brigham and Women's Hospital found that dapagliflozin consistently improved outcomes for both men and women with heart failure, regardless of left ventricular ejection fraction. The treatment was safe and well-tolerated in both sexes, suggesting a lack of sex-specific indications for this class of HF therapies.

SourceBrigham and Women's Hospital·JournalCirculation·TypeRandomized controlled/clinical trial·DateNov 9, 2022